ActHib was tested for safety by giving one group ActHib w/ DTP and the control group was given Hep B w/ DTP. In a randomized, double-blind US clinical trial, ActHIB® was given concomitantly with DTP to more than 5,000 infants and Hepatitis B vaccine was given with DTP to a similar number.